IL23A and skin infection: IL-23-dependent IL-17A production has been shown to be critical for defense against C. albicans skin infection in an epicutaneous infection model using Il17af−/− and Il23a−/− mice [68], and humans with deficiencies in IL-23R signaling show increased susceptibility to CMC [69].